DM Clinical Research

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Graves' disease and hyperthyroidism1 trial
• Obesity1 trial

Phase

• Phase 22 trials

Status

• Recruiting2 trials

Lead sponsor

• Alveus Therapeutics, Inc.1 trial
• Biogen1 trial

Running trials

• Recruiting

  Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  NCT07837973· Phase 2· Alveus Therapeutics, Inc.· Source

  Contact: Principal Investigator

• Recruiting

  A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

  NCT07722546· Phase 2· Biogen· Source

  Contact: Noreen Shaaban (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Graves' disease and hyperthyroidism1 recruiting
• Obesity1 recruiting